North America Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Service (Hematology Products and Services, Hemostasis Products and Services, and Immunohematology Products and Services), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Others), End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, and Research and Academic Institutes), and Country

TIPRE00020128 | Pages: 177 | Medical Device | Mar 2021 | Type: Regional | Status: Published

Market Introduction

Hematology Analyzers and reagents are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting. They are healthcare products and consumables intended to identify and count the individual blood cells in a high-speed manner and highly effective. These instruments have substituted the conventional methods of measuring blood cells individually under a microscope, carried out previously by the lab technicians. These devices provide more precise and useful blood cell results and other related information from the blood sample.

 


Get more information on this report :



Market Overview and Dynamics

The North America hematology analyzers and reagents market is expected to reach US$ 5,302.01million in 2027 from US$ 2,914.69million in 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as the growing prevalence of blood-related disorders and a high development of novel technologies and innovative strategies in hematology analyzers and reagents. However, the market growth is likely to be hindered owing to the product recalls of defective hematology analyzers and reagents.

 

Key Market Segments

Based on product and service, the hematology analyzers and reagents market is segmented into hematology products and services, hemostasis products and services, and immunohematology products and services. The hematology products and services segment is further subdivided into instruments, reagents and consumables, and services. The hemostasis products and services segment is further subdivided into instruments, reagents and consumables, and services. The immunohematology products and services segment is further subdivided into instruments, reagents and consumables, and services. Based on application, the hematology analyzers and reagents market is segmented into anemia, blood cancer, hemorrhagic conditions, infection related conditions, immune system related conditions, and others.  Based on end-user, the hematology analyzers and reagents market, is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research and academic institutes.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources for hematology analyzers and reagents market included in the report are the American Cancer Society, Centers for Disease Control and Prevention (CDC), and others.

 

Reasons to buy the report

  • To understand the North America hematology analyzers and reagents market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for hematology analyzers and reagents market
  • Efficiently plan M&A and partnership deals in North America hematology analyzers and reagents market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form hematology analyzers and reagents market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region

 

 

NORTH AMERICA HEMATOLOGY ANALYZERS AND REAGENTS MARKET SEGMENTATION

 

By Product and Service

  • Hematology Product and Services
    • Instruments
    • Reagents and Consumables
    • Services
  • Hemostasis Product and Services
    • Instruments
    • Reagents and Consumables
    • Services
  • Immunohematology Product and Services
    • Instruments
    • Reagents and Consumables
    • Services

 

By Application

  • Anemia
  • Blood Cancer
  • Haemorrhagic Conditions
  • Infection Related Conditions
  • Immune System Related Conditions
  • Others

 

By End User

  • Hospital Laboratories
  • Commercial Service Providers
  • Government Reference Laboratories
  • Research and Academic Institutes

 

By Country

  • North America
  • US
  • Canada
  • Mexico

 

Company Profiles

  • Clinical Diagnostic Solutions, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Danaher
  • BIO-RAD LABORATORIES INC.
  • Abbott
  • ERBA Diagnostics Inc.
  • EKF Diagnostics
  • HORIBA Medical

 

 

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Hematology Analyzers and Reagents Market – By Product and Service

1.3.2        Hematology Analyzers and Reagents Market – By Application

1.3.3        Hematology Analyzers and Reagents Market – By End User

1.3.4        North America Hematology Analyzers and Reagents Market – By Country

2.          North America Hematology Analyzers and Reagents Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Hematology Analyzers and Reagents Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Hematology Analyzers and Reagents Market- North America PEST Analysis

4.3        Expert Opinion

5.          North America Hematology Analyzers and Reagents Market - Key Market Dynamics

5.1        Market Drivers

5.1.1        Growing Prevalence of Blood-related Disorders

5.1.2        High Development of Novel Technologies and Innovative Strategies in Hematology Analyzers and Reagents

5.2        Market Restraints

5.2.1        Product Recalls of Defective Hematology Analyzers and Reagents

5.3        Market Opportunities

5.3.1        Increasing Awareness Regarding Point-of-Care Testing Methods

5.4        Future Trends

5.4.1        Growing Interest in the Adoption of Microfluidics Technology

5.5        Impact Analysis

6.          Hematology Analyzers and Reagents Market – North America Analysis

6.1        North America Hematology Analyzers and Reagents Market Revenue Forecasts and Analysis

7.          North America Hematology Analyzers and Reagents Market Analysis and Forecasts To 2027 – ByProduct and Service

7.1        Overview

7.2        Hematology Analyzers and Reagents Market, by Product and Service, 2019 and 2027 (%)

7.3        Hematology Products and Services

7.3.1        Overview

7.3.2        Hematology Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3        Instruments

7.3.3.1          Overview

7.3.3.2          Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4        Reagents and Consumables

7.3.4.1          Overview

7.3.4.2          Reagents and Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.5        Services

7.3.5.1          Overview

7.3.5.2          Services Market Revenue and Forecasts to 2027 (US$ Mn)

7.4        Hemostasis Products and Services

7.4.1        Overview

7.4.2        Hemostasis Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        Instruments

7.4.3.1          Overview

7.4.3.2          Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.4        Reagents and Consumables

7.4.4.1          Overview

7.4.4.2          Reagents and Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.5        Services

7.4.5.1          Overview

7.4.5.2          Services Market Revenue and Forecasts to 2027 (US$ Mn)

7.5        Immunohematology Products and Services

7.5.1        Overview

7.5.2        Immunohematology Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)

7.5.3        Instruments

7.5.3.1          Overview

7.5.3.2          Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

7.5.4        Reagents and Consumables

7.5.4.1          Overview

7.5.4.2          Reagents and Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

7.5.5        Services

7.5.5.1          Overview

7.5.5.2          Services Market Revenue and Forecasts to 2027 (US$ Mn)

8.          North America Hematology Analyzers and Reagents Market Analysis – ByApplication

8.1        Overview

8.2        Hematology Analyzers and Reagents Market, by Application, 2019 and 2027 (%)

8.3        Anemia

8.3.1        Overview

8.3.2        Anemia Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Blood Cancer

8.4.1        Overview

8.4.2        Blood Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

8.5        Haemorrhagic Conditions

8.5.1        Overview

8.5.2        Haemorrhagic Conditions Market Revenue and Forecasts to 2027 (US$ Mn)

8.6        Infection Related Conditions

8.6.1        Overview

8.6.2        Infection Related Conditions Market Revenue and Forecasts to 2027 (US$ Mn)

8.7        Immune System Related Conditions

8.7.1        Overview

8.7.2        Immune System Related Conditions Market Revenue and Forecasts to 2027 (US$ Mn)

8.8        Others

8.8.1        Overview

8.8.2        Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.          North America Hematology Analyzers and Reagents Market Analysis – By End-User

9.1        Overview

9.2        Hematology Analyzers and Reagents Market, by End User, 2019 and 2027 (%)

9.3        Hospital Laboratories

9.3.1        Overview

9.3.2        Hospital Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.4        Commercial Service Providers

9.4.1        Overview

9.4.2        Commercial Service Providers Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Government Reference Laboratories

9.5.1        Overview

9.5.2        Government Reference Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Academic and Research Institutes

9.6.1        Overview

9.6.2        Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

10.       Hematology Analyzers and Reagents Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1      North America: Hematology Analyzers and Reagents Market

10.1.1     Overview

10.1.2     North America: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America: Hematology Analyzers and Reagents Market, by Product and Service, 2018–2027 (USD Million)

10.1.3.1       North America: Hematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.3.2       North America: Hemostasis Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.3.3       North America: Immunohematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.4     North America: Hematology Analyzers and Reagents Market, by Application, 2018–2027 (USD Million)

10.1.5     North America: Hematology Analyzers and Reagents Market, by End User, 2018–2027 (USD Million)

10.1.6     North America: Hematology Analyzers and Reagents Market, by Country, 2019 & 2027 (%)

10.1.7     US: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       US: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       US: Hematology Analyzers and Reagents Market, by Product and Service, 2018–2027 (USD Million)

10.1.7.2.1       US: Hematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.7.2.2       US: Hemostasis Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.7.2.3       US: Immunohematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.7.3       US: Hematology Analyzers and Reagents Market, by Application, 2018–2027 (USD Million)

10.1.7.4       US: Hematology Analyzers and Reagents Market, by End User, 2018–2027 (USD Million)

10.1.8     Canada: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Canada: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Canada: Hematology Analyzers and Reagents Market, by Product and Service, 2018–2027 (USD Million)

10.1.8.2.1       Canada: Hematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.8.2.2       Canada: Hemostasis Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.8.2.3       Canada: Immunohematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.8.3       Canada: Hematology Analyzers and Reagents Market, by Application, 2018–2027 (USD Million)

10.1.8.4       Canada: Hematology Analyzers and Reagents Market, by End User, 2018–2027 (USD million)

10.1.9     Mexico: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Mexico: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Mexico: Hematology Analyzers and Reagents Market, by Product and Service, 2018–2027 (USD Million)

10.1.9.2.1       Mexico: Hematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.9.2.2       Mexico: Hemostasis Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.9.2.3       Mexico: Immunohematology Products and Services Market, by Type, 2018–2027 (USD Million)

10.1.9.3       Mexico: Hematology Analyzers and Reagents Market, by Application, 2018–2027 (USD Million)

10.1.9.4       Mexico: Hematology Analyzers and Reagents Market, by End User, 2018–2027 (USD million)

11.       Impact of COVID-19 Pandemic on North America Hematology Analyzers and Reagents Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.       COMPANY PROFILES

12.1      Clinical Diagnostic Solutions, Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Danaher

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BIO-RAD LABORATORIES INC.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Abbott

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      ERBA Diagnostics Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      EKF Diagnostics

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      HORIBA Medical

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.       Appendix

13.1      About the Insight Partners

13.2      Glossary of terms

LIST OF TABLES

Table 1.            North America Hematology Analyzers and Reagents Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 2.            North America Hematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.            North America Hemostasis Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.            North America Immunohematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.            North America Hematology Analyzers and Reagents Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.            North America Hematology Analyzers and Reagents Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.            US Hematology Analyzers and Reagents Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 8.            US Hematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.            US Hemostasis Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          US Immunohematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          US Hematology Analyzers and Reagents Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.          US Hematology Analyzers and Reagents Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada Hematology Analyzers and Reagents Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada Hematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada Hemostasis Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          Canada Immunohematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Canada Hematology Analyzers and Reagents Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 18.          Canada Hematology Analyzers and Reagents Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico Hematology Analyzers and Reagents Market, by Product and Service – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico Hematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21.          Mexico Hemostasis Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Mexico Immunohematology Products and Services Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 23.          Mexico Hematology Analyzers and Reagents Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 24.          Mexico Hematology Analyzers and Reagents Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 25.          Glossary of Terms,Hematology Analyzers and Reagents Market

LIST OF FIGURES

Figure 1.           Hematology Analyzers and ReagentsMarket Segmentation

Figure 2.           North America Hematology Analyzers and Reagents Market Overview

Figure 3.           Hematology Products and ServicesSegment Held Largest Share of Product and Service inHematology Analyzers and ReagentsMarket

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Hematology Analyzers and Reagents Market - North America PEST Analysis

Figure 6.           Hematology Analyzers and Reagents Market Impact Analysis of Driver and Restraints

Figure 7.           North America Hematology Analyzers and Reagents Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Hematology Analyzers and Reagents Market breakdown, by Product and Service, 2019 and 2027 (%)

Figure 9.           Hematology Products and Services Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 10.        Instruments Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 11.        Reagents and Consumables Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 12.        Services Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 13.        Hemostasis Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Reagents and Consumables Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 16.        Services Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 17.        Immunohematology Products and Services Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Instruments Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Reagents and Consumables Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 20.        Services Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 21.        Hematology Analyzers and Reagents Market Breakdown, by Application 2019 and 2027 (%)

Figure 22.        Anemia Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 23.        Blood Cancer Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        Hemorrhagic Conditions Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Infection Related Conditions Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Immune System Related Conditions Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Hematology Analyzers and Reagents Market, by End User 2019 and 2027 (%)

Figure 29.        Hospital Laboratories Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 30.        Commercial Service Providers Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 31.        Government Reference Laboratories Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 32.        Academic and Research Institutes Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 33.        North America: Hematology Analyzers and Reagents Market, by Key Country – Revenue (2019) (USD Million)

Figure 34.        North America Hematology Analyzers and Reagents Market Revenue and Forecast to 2027 (USD Million)

Figure 35.        North America: Hematology Analyzers and Reagents Market, by Country, 2019 & 2027 (%)

Figure 36.        US: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.        Canada: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Mexico: Hematology Analyzers and Reagents Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Impact of COVID-19 Pandemic in North America Country Markets

 

  1. Clinical Diagnostic Solutions, Inc.
  2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  3. Danaher
  4. BIO-RAD LABORATORIES INC.
  5. Abbott
  6. ERBA Diagnostics Inc.
  7. EKF Diagnostics
  8. HORIBA Medical
  • To understand the North America hematology analyzers and reagents market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for hematology analyzers and reagents market
  • Efficiently plan M&A and partnership deals in North America hematology analyzers and reagents market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form hematology analyzers and reagents market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000